1. Home
  2. EXPI vs DBVT Comparison

EXPI vs DBVT Comparison

Compare EXPI & DBVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo eXp World Holdings Inc.

EXPI

eXp World Holdings Inc.

HOLD

Current Price

$5.98

Market Cap

1.0B

Sector

Finance

ML Signal

HOLD

DBVT

DBV Technologies S.A.

HOLD

Current Price

$20.95

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EXPI
DBVT
Founded
2008
2002
Country
United States
France
Employees
N/A
90
Industry
Real Estate
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.1B
IPO Year
2010
2014

Fundamental Metrics

Financial Performance
Metric
EXPI
DBVT
Price
$5.98
$20.95
Analyst Decision
Strong Buy
Buy
Analyst Count
2
7
Target Price
$9.75
$32.04
AVG Volume (30 Days)
1.0M
252.2K
Earning Date
05-05-2026
03-26-2026
Dividend Yield
3.34%
N/A
EPS Growth
N/A
10.26
EPS
N/A
N/A
Revenue
$500,147,681.00
$5,636,000.00
Revenue This Year
$6.93
$79.21
Revenue Next Year
$5.37
$1,754.26
P/E Ratio
N/A
N/A
Revenue Growth
220.39
35.77
52 Week Low
$5.66
$6.00
52 Week High
$12.23
$26.19

Technical Indicators

Market Signals
Indicator
EXPI
DBVT
Relative Strength Index (RSI) 35.34 51.33
Support Level $5.66 $20.23
Resistance Level $6.31 $24.16
Average True Range (ATR) 0.29 1.12
MACD 0.08 0.02
Stochastic Oscillator 49.26 73.10

Price Performance

Historical Comparison
EXPI
DBVT

About EXPI eXp World Holdings Inc.

eXp World Holdings Inc is a cloud-based residential real estate company. The company owns and operates a cloud-based real estate brokerage and a technology platform business that develops and uses immersive technologies that help businesses increase their effectiveness and reduce costs from operating in traditional brick-and-mortar office spaces. Its business categories include Real Estate Brokerage, Technology Products and Services, Title, Escrow, Settlement Services, and Mortgage Brokerage Services.

About DBVT DBV Technologies S.A.

DBV Technologies SA is a clinical-stage specialty biopharmaceutical company focused on changing the field of immunotherapy by developing a novel technology platform called Viaskin. The therapeutic approach is based on epicutaneous immunotherapy or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin, an epicutaneous patch (i.e., a skin patch). Its main product candidate under development is Viaskin Peanut for the treatment of peanut-allergic patients. In addition, the company also has earlier-stage food allergy programs, including Viaskin Milk and Eosinophilic Esophagitis, or EoE.

Share on Social Networks: